|
Volumn 3, Issue 12, 2012, Pages 1555-1561
|
Engineering of peglayted camptothecin into core-shell nanomicelles for improving solubility, stability and combination delivery
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAMPTOTHECIN DERIVATIVE;
CAMPTOTHECIN PLUS DOXORUBICIN;
DOXORUBICIN;
MACROGOL;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CELL PROLIFERATION;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
DRUG CONJUGATION;
DRUG CYTOTOXICITY;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG POTENCY;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG UPTAKE;
FEMALE;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MICELLE;
NANOENCAPSULATION;
NANOENGINEERING;
NANOMICELLE;
NANOPHARMACEUTICS;
PRIORITY JOURNAL;
|
EID: 84870025623
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c2md20153d Document Type: Article |
Times cited : (19)
|
References (25)
|